Quarterly Results

KOBO BIOTECH LTD.

NSE : NABSE : 531541ISIN CODE : INE881A01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.08-0.01 (-0.24 %)
PREV CLOSE ( ) 4.09
OPEN PRICE ( ) 4.08
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10233
TODAY'S LOW / HIGH ( )3.89 4.09
52 WK LOW / HIGH ( ) 2.046.01
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
NA
NA
NA
NA
Total Expenditure
2.03
1.95
2.28
7.9
PBIDT (Excl OI)
-2.03
-1.95
-2.28
-7.9
Other Income
NA
NA
0.15
NA
Operating Profit
-2.03
-1.95
-2.13
-7.9
Interest
0.00
NA
NA
NA
Exceptional Items
NA
NA
NA
NA
PBDT
-2.03
-1.95
-2.13
-7.9
Depreciation
10.28
10.2
10.13
10.03
Profit Before Tax
-12.31
-12.15
-12.26
-17.93
Tax
NA
NA
NA
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-12.31
-12.15
-12.26
-17.93
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-12.31
-12.15
-12.26
-17.93
Equity Capital
238.25
238.25
238.25
238.25
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
-0.51
-0.50
-0.51
-0.75
Calculated EPS (Annualised)
-2.06
-2.03
-2.05
-3.01
No of Public Share Holdings
13115900
13115900
13115900
13115900
% of Public Share Holdings
55.05
55.05
55.05
55.05
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
NA
NA
NA
NA
PBIDTM%
NA
NA
NA
NA
PBDTM%
NA
NA
NA
NA
PBTM%
NA
NA
NA
NA
PATM%
NA
NA
NA
NA
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.